Market revenue in 2022 | USD 826.6 million |
Market revenue in 2030 | USD 1,585.1 million |
Growth rate | 8.5% (CAGR from 2022 to 2030) |
Largest segment | Lead identification & candidate optimization |
Fastest growing segment | Other Associated Workflow |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 32.36% in 2022. Horizon Databook has segmented the Asia Pacific drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific drug discovery outsourcing market is expected to witness the fastest growth over the forecast period. The emerging economies of Asian countries are a major factor contributing to the growth of this region as most of the patients in this region pay costs of pharmaceuticals out-of-pocket.
Ongoing studies in drug discovery, private-public collaborations, and government initiatives are some of the other factors likely to propel the growth of Asian drug discovery outsourcing market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug discovery outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account